Influence of Acute and Chronic Exercise on Glucose Uptake

Journal of Diabetes Research

Volumn 2016, Issue , 2016, Pages

  Röhling, Martin ^a,b   Herder, Christian ^a,b   Stemper, Theodor ^c   Müssig, Karsten ^a,b  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b GERMAN CENTER FOR DIABETES RESEARCH DZD   (Germany)

^c UNIVERSITY OF WUPPERTAL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; AKT SUBSTRATE OF 160 KDA; CALCIUM; CALMODULIN; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INFLAMMASOME; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN; PROTEIN KINASE B; RAC1 PROTEIN; S6 KINASE; STRESS ACTIVATED PROTEIN KINASE; TBC1 DOMAIN FAMILY MEMBERS 1; TBC1 DOMAIN FAMILY MEMBERS 2; UNCLASSIFIED DRUG; AUTACOID; GLUCOSE BLOOD LEVEL;

ACUTE EXERCISE; CHRONIC EXERCISE; DIABETES MELLITUS; EXERCISE; GLUCOSE TRANSPORT; HUMAN; INFLAMMATION; META ANALYSIS; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SYSTEMATIC REVIEW; ANIMAL; BLOOD; DIABETES MELLITUS, TYPE 2; ENERGY METABOLISM; GLUCOSE BLOOD LEVEL; LIFESTYLE; METABOLISM; MUSCLE CONTRACTION; PROTECTION; RISK FACTOR; RISK REDUCTION; SKELETAL MUSCLE; TIME FACTOR;

ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; ENERGY METABOLISM; EXERCISE; HUMANS; INFLAMMATION MEDIATORS; INSULIN; LIFE STYLE; MUSCLE CONTRACTION; MUSCLE, SKELETAL; PROTECTIVE FACTORS; RISK FACTORS; RISK REDUCTION BEHAVIOR; SIGNAL TRANSDUCTION; TIME FACTORS;

EID: 84962909266     PISSN: 23146745     EISSN: 23146753     Source Type: Journal    
DOI: 10.1155/2016/2868652     Document Type: Review

References (176)

1. A. V. Ardisson Korat, W. C. Willett, and F. B. Hu, "Diet, lifestyle, and genetic risk factors for type 2 diabetes: A review from the Nurses' Health Study, Nurses' Health Study 2, and Health Professionals' Follow-up study, " Current Nutrition Reports, vol. 3, no. 4, pp. 345-354, 2014.
2. R. Ringseis, K. Eder, F. C. Mooren, and K. Krüger, "Metabolic signals and innate immune activation in obesity and exercise, " Exercise Immunology Review, vol. 21, pp. 58-68, 2015.
3. Y. Hayashino, J. L. Jackson, T. Hirata et al., "Effects of exercise on C-reactive protein, inflammatory cytokine and adipokine in patients with type 2 diabetes: A meta-analysis of randomized controlled trials, " Metabolism, vol. 63, no. 3, pp. 431-440, 2014.
4. E. J. Henriksen, "Invited review: effects of acute exercise and exercise training on insulin resistance, " Journal of Applied Physiology, vol. 93, no. 2, pp. 788-796, 2002.
5. I. K. Martin, A. Katz, and J. Wahren, "Splanchnic and muscle metabolism during exercise in NIDDMpatients, " The American Journal of Physiology, vol. 269, no. 3, pp. E583-E590, 1995.
6. M. C. F. Passos and M. C. Gonçalves, "Regulation of insulin sensitivity by adiponectin and its receptors in response to physical exercise, " Hormone and Metabolic Research, vol. 46, no. 9, pp. 603-608, 2014.
7. J.-A. Simoneau, J. H. Veerkamp, L. P. Turcotte, and D. E. Kelley, "Markers of capacity to utilize fatty acids in human skeletal muscle: relation to insulin resistance and obesity and effects of weight loss, " The FASEB Journal, vol. 13, no. 14, pp. 2051-2060, 1999.
8. B. Egan and J. R. Zierath, "Exercise metabolism and the molecular regulation of skeletal muscle adaptation, " Cell Metabolism, vol. 17, no. 2, pp. 162-184, 2013.
9. L. E. Gosselin, K. F. Kozlowski, L. Devinney-Boymel, and C. Hambridge, "Metabolic response of different high-intensity aerobic interval exercise protocols, " Journal of Strength and Conditioning Research, vol. 26, no. 10, pp. 2866-2871, 2012.
10. J. R. Silva, G. P. Nassis, and A. Rebelo, "Strength training in soccer with a specific focus on highly trained players, " Sports Medicine-Open, vol. 1, article 17, 2015.
11. P. D. Thompson, S. F. Crouse, B. Goodpaster, D. Kelley, N. Moyna, and L. Pescatello, "The acute versus the chronic response to exercise, " Medicine and Science in Sports and Exercise, vol. 33, no. 6, pp. S438-S445, 2001.
12. K. Cusi, K. Maezono, A. Osman et al., "Insulin resistance differentially affects the PI 3-kinase-andMAP kinase-mediated signaling in human muscle, " The Journal of Clinical Investigation, vol. 105, no. 3, pp. 311-320, 2000.
13. G. Perseghin, T. B. Price, K. F. Petersen et al., "Increased glucose transport-phosphorylation and muscle glycogen synthesis after exercise training in insulin-resistant subjects, " The New England Journal of Medicine, vol. 335, no. 18, pp. 1357-1362, 1996.
14. J. P. Kirwan, L. F. del Aguila, J. M. Hernandez et al., "Regular exercise enhances insulin activation of IRS-1-associated PI3-kinase in human skeletalmuscle, " Journal of Applied Physiology, vol. 88, no. 2, pp. 797-803, 2000.
15. K. F. Howlett, K. Sakamoto, H. Yu, L. J. Goodyear, and M. Hargreaves, "Insulin-stimulated insulin receptor substrate-2-associated phosphatidylinositol 3-kinase activity is enhanced in human skeletal muscle after exercise, " Metabolism: Clinical and Experimental, vol. 55, no. 8, pp. 1046-1052, 2006.
16. A. Deshmukh, V. G. Coffey, Z. Zhong, A. V. Chibalin, J. A. Hawley, and J. R. Zierath, "Exercise-induced phosphorylation of the novel Akt substrates AS160 and filamin A in human skeletal muscle, " Diabetes, vol. 55, no. 6, pp. 1776-1782, 2006.
17. J. L. Treadway, D. E. James, E. Burcel, and N. B. Ruderman, "Effect of exercise on insulin receptor binding and kinase activity in skeletal muscle, " The American Journal of Physiology- Endocrinology and Metabolism, vol. 256, no. 1, pp. E138-E144, 1989.
18. L. J. Goodyear, F. Giorgino, T. W. Balon, G. Condorelli, and R. J. Smith, "Effects of contractile activity on tyrosine phosphoproteins and PI 3-kinase activity in rat skeletal muscle, " American Journal of Physiology-Endocrinology andMetabolism, vol. 268, no. 5, pp. 987-995, 1995.
19. D. J. O'Gorman, H. K. R. Karlsson, S. McQuaid et al., "Exercise training increases insulin-stimulated glucose disposal and GLUT4 (SLC2A4) protein content in patients with type 2 diabetes, " Diabetologia, vol. 49, no. 12, pp. 2983-2992, 2006.
20. G. D. Wadley, N. Konstantopoulos, L. Macaulay et al., "Increased insulin-stimulated Akt pSer473 and cytosolic SHP2 protein abundance in human skeletal muscle following acute exercise and short-termtraining, " Journal of Applied Physiology, vol. 102, no. 4, pp. 1624-1631, 2007.
21. J. F. P. Wojtaszewski, B. F. Hansen, J. Gade et al., "Insulin signaling and insulin sensitivity after exercise in human skeletal muscle, " Diabetes, vol. 49, no. 3, pp. 325-331, 2000.
22. C. Frøsig and E. A. Richter, "Improved insulin sensitivity after exercise: focus on insulin signaling, " Obesity, vol. 17, no. 3, pp. S15-S20, 2009.
23. B. E. Kemp, K. I. Mitchelhill, D. Stapleton, B. J. Michell, Z.-P. Chen, and L. A. Witters, "Dealing with energy demand: The AMP-activated protein kinase, " Trends in Biochemical Sciences, vol. 24, no. 1, pp. 22-25, 1999.
24. N. Musi, N. Fujii, M. F. Hirshman et al., "AMP-activated protein kinase (AMPK) is activated in muscle of subjects with type 2 diabetes during exercise, " Diabetes, vol. 50, no. 5, pp. 921-927, 2001.
25. A. Sriwijitkamol, D. K. Coletta, E. Wajcberg et al., "Effect of acute exercise onAMPK signaling in skeletalmuscle of subjects with type 2 diabetes: A time-course and dose-response study, " Diabetes, vol. 56, no. 3, pp. 836-848, 2007.
26. B. Benziane, T. J. Burton, B. Scanlan et al., "Divergent cell signaling after short-term intensified endurance training in human skeletal muscle, " American Journal of Physiology- Endocrinology andMetabolism, vol. 295, no. 6, pp. E1427-E1438, 2008.
27. B. Egan, B. P. Carson, P. M. Garcia-Roves et al., "Exercise intensity-dependent regulation of peroxisome proliferatoractivated receptor í coactivator-1í mRNA abundance is associated with differential activation of upstream signalling kinases in human skeletal muscle, " The Journal of Physiology, vol. 588, no. 10, pp. 1779-1790, 2010.
28. M. J. Gibala, S. L. McGee, A. P. Garnham, K. F. Howlett, R. J. Snow, and M. Hargreaves, "Brief intense interval exercise activates AMPK and p38 MAPK signaling and increases the expression of PGC-1í in human skeletal muscle, " Journal of Applied Physiology, vol. 106, no. 3, pp. 929-934, 2009.
29. K. Vissing, S. L. McGee, J. Farup, T. Kjølhede, M. H. Vendelbo, and N. Jessen, "Differentiated mTOR but not AMPK signaling after strength vs endurance exercise in training-accustomed individuals, " Scandinavian Journal of Medicine and Science in Sports, vol. 23, no. 3, pp. 355-366, 2013.
30. L. Luo, A.-M. Lu, Y. Wang et al., "Chronic resistance training activates autophagy and reduces apoptosis of muscle cells by modulating IGF-1 and its receptors, Akt/mTOR and Akt/FOXO3a signaling in aged rats, " Experimental Gerontology, vol. 48, no. 4, pp. 427-436, 2013.
31. V. C. Calegari, C. C. Zoppi, L. F. Rezende, L. R. Silveira, E. M. Carneiro, and A. C. Boschero, "Endurance training activates AMP-activated protein kinase, increases expression of uncoupling protein 2 and reduces insulin secretion from rat pancreatic islets, " Journal of Endocrinology, vol. 208, no. 3, pp. 257-264, 2011.
32. K. I. Stanford and L. J. Goodyear, "Exercise and type 2 diabetes: molecular mechanisms regulating glucose uptake in skeletal muscle, " Advances in Physiology Education, vol. 38, no. 4, pp. 308-314, 2014.
33. M. D. Nitert, T. Dayeh, P. Volkov et al., "Impact of an exercise intervention on DNAmethylation in skeletalmuscle fromfirstdegree relatives of patients with type 2 diabetes, " Diabetes, vol. 61, no. 12, pp. 3322-3332, 2012.
34. A. J. Rose, B. Kiens, and E. A. Richter, "Ca2+-calmodulindependent protein kinase expression and signalling in skeletal muscle during exercise, " Journal of Physiology, vol. 574, no. 3, pp. 889-903, 2006.
35. A. Combes, J. Dekerle, N. Webborn, P. Watt, V. Bougault, and F. N. Daussin, "Exercise?induced metabolic fluctuations influence AMPK, p38?MAPK and CaMKII phosphorylation in human skeletal muscle, " Physiological Reports, vol. 3, Article ID e12462, 2015.
36. A. Katta, S. Kakarla, M. Wu et al., "Altered regulation of contraction-induced Akt/mTOR/p70S6k pathway signaling in skeletal muscle of the obese Zucker rat, " Experimental Diabetes Research, vol. 2009, Article ID 384683, 9 pages, 2009.
37. A. Philp, D. L. Hamilton, and K. Baar, "Signals mediating skeletal muscle remodeling by resistance exercise: PI3-kinase independent activation of mTORC1, " Journal of Applied Physiology, vol. 110, no. 2, pp. 561-568, 1985.
38. C. A. Stuart, M. E. A. Howell, J. D. Baker et al., "Cycle training increased glut4 and activation of mammalian target of rapamycin in fast twitch muscle fibers, "Medicine and Science in Sports and Exercise, vol. 42, no. 1, pp. 96-106, 2010.
39. D. M. Camera, J. Edge, M. J. Short, J. A. Hawley, and V. G. Coffey, "Early time course of akt phosphorylation after endurance and resistance exercise, "Medicine and Science in Sports and Exercise, vol. 42, no. 10, pp. 1843-1852, 2010.
40. H. C. Dreyer, S. Fujita, J. G. Cadenas, D. L. Chinkes, E. Volpi, and B. B. Rasmussen, "Resistance exercise increases AMPK activity and reduces 4E-BP1 phosphorylation and protein synthesis in human skeletal muscle, " Journal of Physiology, vol. 576, no. 2, pp. 613-624, 2006.
41. D. M. Thomson, C. A. Fick, and S. E. Gordon, "AMPKactivation attenuates S6K1, 4E-BP1, and eEF2 signaling responses to highfrequency electrically stimulated skeletal muscle contractions, " Journal of Applied Physiology, vol. 104, no. 3, pp. 625-632, 2008.
42. K. Inoki, H. Ouyang, T. Zhu et al., "TSC2 integrates Wnt and energy signals via a coordinated phosphorylation byAMPKand GSK3 to regulate cell growth, " Cell, vol. 126, no. 5, pp. 955-968, 2006.
43. H. Mascher, B. Ekblom, O. Rooyackers, and E. Blomstrand, "Enhanced rates of muscle protein synthesis and elevated mTOR signalling following endurance exercise in human subjects, " Acta Physiologica, vol. 202, no. 2, pp. 175-184, 2011.
44. S. Fujita, B. B. Rasmussen, J. G. Cadenas et al., "Aerobic exercise overcomes the age-related insulin resistance of muscle protein metabolism by improving endothelial function and Akt/mammalian target of rapamycin signaling, " Diabetes, vol. 56, no. 6, pp. 1615-1622, 2007.
45. J. K. Pugh, S. H. Faulkner, A. P. Jackson, J. A. King, and M. A. Nimmo, "Acute molecular responses to concurrent resistance and high-intensity interval exercise in untrained skeletal muscle, " Physiological Reports, vol. 3, no. 4, Article ID e12364, 2015.
46. B. A. Edgett, M. L. Fortner, A. Bonen, and B. J. Gurd, "Mammalian target of rapamycin pathway is up-regulated by both acute endurance exercise and chronic muscle contraction in rat skeletal muscle, " Applied Physiology, Nutrition and Metabolism, vol. 38, no. 8, pp. 862-869, 2013.
47. S. J. Maarbjerg, L. Sylow, and E. A. Richter, "Current understanding of increased insulin sensitivity after exercise- emerging candidates, " Acta Physiologica, vol. 202, no. 3, pp. 323-335, 2011.
48. L. Sylow, M. Kleinert, C. Pehmøller et al., "Akt and Rac1 signaling are jointly required for insulin-stimulated glucose uptake in skeletal muscle and downregulated in insulin resistance, " Cellular Signalling, vol. 26, no. 2, pp. 323-331, 2014.
49. C. M. Castorena, E. B. Arias, N. Sharma, and G. D. Cartee, "Postexercise improvement in insulin-stimulated glucose uptake occurs concomitantwith greaterAS160 phosphorylation inmuscle fromnormal and insulin-resistant rats, " Diabetes, vol. 63, no. 7, pp. 2297-2308, 2014.
50. K. Sakamoto, M. F. Hirshman, W. G. Aschenbach, and L. J. Goodyear, "Contraction regulation of Akt in rat skeletal muscle, " The Journal of Biological Chemistry, vol. 277, no. 14, pp. 11910-11917, 2002.
51. J. F. P. Wojtaszewski, Y. Higaki, M. F. Hirshman et al., "Exercise modulates postreceptor insulin signaling and glucose transport in muscle-specific insulin receptor knockout mice, " Journal of Clinical Investigation, vol. 104, no. 9, pp. 1257-1264, 1999.
52. L. A. Consitt, J. Van Meter, C. A. Newton et al., "Impairments in site-specific AS160 phosphorylation and effects of exercise training, " Diabetes, vol. 62, no. 10, pp. 3437-3447, 2013.
53. I. R. Ritchie, D. C. Wright, and D. J. Dyck, "Adiponectin is not required for exercise training-induced improvements in glucose and insulin tolerance in mice, " Physiological Reports, vol. 2, no. 9, Article ID e12146, 2014.
54. M. H. Vendelbo, A. B. Møller, J. T. Treebak et al., "Sustained AS160 and TBC1D1 phosphorylations in human skeletalmuscle 30 min after a single bout of exercise, " Journal of Applied Physiology, vol. 117, no. 3, pp. 289-296, 2014.
55. J. T. Treebak, J. B. Birk, A. J. Rose, B. Kiens, E. A. Richter, and J. F. P. Wojtaszewski, "AS160 phosphorylation is associated with activation of í 2í2í1-but not í 2í2í3-AMPKtrimeric complex in skeletal muscle during exercise in humans, " The American Journal of Physiology-Endocrinology and Metabolism, vol. 292, no. 3, pp. E715-E722, 2007.
56. J. T. Treebak, C. Frøsig, C. Pehmøller et al., "Potential role of TBC1D4 in enhanced post-exercise insulin action in human skeletal muscle, " Diabetologia, vol. 52, no. 5, pp. 891-900, 2009.
57. M. D. Bruss, E. B. Arias, G. E. Lienhard, and G. D. Cartee, "Increased phosphorylation ofAkt substrate of 160 kDa (AS160) in rat skeletal muscle in response to insulin or contractile activity, " Diabetes, vol. 54, no. 1, pp. 41-50, 2005.
58. L. Sylow, L. L. Møller, M. Kleinert, E. A. Richter, and T. E. Jensen, "Rac1-a novel regulator of contraction-stimulated glucose uptake in skeletalmuscle, " Experimental Physiology, vol. 99, no. 12, pp. 1574-1580, 2014.
59. L. Sylow, T. E. Jensen, M. Kleinert et al., "Rac1 is a novel regulator of contraction-stimulated glucose uptake in skeletal muscle, " Diabetes, vol. 62, no. 4, pp. 1139-1151, 2013.
60. L. Sylow, L. L. V. Møller, M. Kleinert, E. A. Richter, and T. E. Jensen, "Stretch-stimulated glucose transport in skeletalmuscle is regulated by Rac1, " Journal of Physiology, vol. 593, no. 3, pp. 645-656, 2015.
61. N. Kawanishi, H. Yano, Y. Yokogawa, and K. Suzuki, "Exercise training inhibits inflammation in adipose tissue via both suppression of macrophage infiltration and acceleration of phenotypic switching fromM1 toM2 macrophages in high-fatdiet-induced obese mice, " Exercise Immunology Review, vol. 16, pp. 105-118, 2010.
62. N. Kawanishi, T. Mizokami, H. Yano, and K. Suzuki, "Exercise attenuates M1 macrophages and CD8+ T cells in the adipose tissue of obese mice, " Medicine and Science in Sports and Exercise, vol. 45, no. 9, pp. 1684-1693, 2013.
63. A. Sriwijitkamol, C. Christ-Roberts, R. Berria et al., "Reduced skeletal muscle inhibitor of íBí content is associated with insulin resistance in subjects with type 2 diabetes: reversal by exercise training, " Diabetes, vol. 55, no. 3, pp. 760-767, 2006.
64. G. I. Lancaster, Q. Khan, P. Drysdale et al., "The physiological regulation of toll-like receptor expression and function in humans, " The Journal of Physiology, vol. 563, no. 3, pp. 945-955, 2005.
65. M. Oliveira and M. Gleeson, "The influence of prolonged cycling on monocyte Toll-like receptor 2 and 4 expression in healthy men, " European Journal of Applied Physiology, vol. 109, no. 2, pp. 251-257, 2010.
66. P. Rodriguez-Miguelez, R. Fernandez-Gonzalo, M. Almar et al., "Role of Toll-like receptor 2 and 4 signaling pathways on the inflammatory response to resistance training in elderly subjects, " Age, vol. 36, article 9734, 2014.
67. G. da Luz, M. J. S. Frederico, S. da Silva et al., "Endurance exercise training ameliorates insulin resistance and reticulum stress in adipose and hepatic tissue in obese rats, " European Journal of Applied Physiology, vol. 111, no. 9, pp. 2015-2023, 2011.
68. C. Medeiros, M. J. Frederico, G. da Luz et al., "Exercise training reduces insulin resistance and upregulates the mTOR/p70S6k pathway in cardiacmuscle of diet-induced obesity rats, " Journal of Cellular Physiology, vol. 226, no. 3, pp. 666-674, 2011.
69. A. G. Oliveira, B. M. Carvalho, N. Tobar et al., "Physical exercise reduces circulating lipopolysaccharide and TLR4 activation and improves insulin signaling in tissues of DIO rats, " Diabetes, vol. 60, no. 3, pp. 784-796, 2011.
70. D. Lyngsø, L. Simonsen, and J. Bülow, "Interleukin-6 production in human subcutaneous abdominal adipose tissue: The effect of exercise, " Journal of Physiology, vol. 543, no. 1, pp. 373-378, 2002.
71. C. P. Fischer, "Interleukin-6 in acute exercise and training: what is the biological relevance?" Exercise Immunology Review, vol. 12, pp. 6-33, 2006.
72. K. Ostrowski, T. Rohde, M. Zacho, S. Asp, and B. K. Pedersen, "Evidence that interleukin-6 is produced in human skeletal muscle during prolonged running, " The Journal of Physiology, vol. 508, no. 3, pp. 949-953, 1998.
73. M. Leggate, M. A. Nowell, S. A. Jones, and M. A. Nimmo, "The response of interleukin-6 and soluble interleukin-6 receptor isoforms following intermittent high intensity and continuous moderate intensity cycling, " Cell Stress and Chaperones, vol. 15, no. 6, pp. 827-833, 2010.
74. L. Castellani, C. G. Perry, R. E. MacPherson et al., "Exercisemediated IL-6 signaling occurs independent of inflammation and is amplified by training in mouse adipose tissue, " Journal of Applied Physiology, vol. 119, pp. 1347-1354, 2015.
75. R. E. Macpherson, J. S. Huber, S. Frendo-Cumbo, J. A. Simpson, and D. C. Wright, "Adipose tissue insulin action and IL-6 signaling after exercise in obese mice, " Medicine & Science in Sports & Exercise, vol. 47, no. 10, pp. 2034-2042, 2015.
76. A. M. W. Petersen and B. K. Pedersen, "The anti-inflammatory effect of exercise, " Journal of Applied Physiology, vol. 98, no. 4, pp. 1154-1162, 2005.
77. E. Hopps, B. Canino, and G. Caimi, "Effects of exercise on inflammation markers in type 2 diabetic subjects, " Acta Diabetologica, vol. 48, no. 3, pp. 183-189, 2011.
78. N. P. Kadoglou, D. Perrea, F. Iliadis, N. Angelopoulou, C. Liapis, and M. Alevizos, "Exercise reduces resistin and inflammatory cytokines in patients with type 2 diabetes, " Diabetes Care, vol. 30, no. 3, pp. 719-721, 2007.
79. L. Leick, B. Lindegaard, D. Stensvold, P. Plomgaard, B. Saltin, and H. Pilegaard, "Adipose tissue interleukin-18 mRNA and plasma interleukin-18: effect of obesity and exercise, " Obesity, vol. 15, no. 2, pp. 356-363, 2007.
80. C. Mardare, K. Krüger, G. Liebisch et al., "Endurance and resistance training affect high fat diet-induced increase of ceramides, inflammasome expression, and systemic inflammation in mice, " Journal of Diabetes Research, vol. 2016, Article ID 4536470, 13 pages, 2016.
81. M. Whitham, M. H. S. Chan, M. Pal et al., "Contractioninduced interleukin-6 gene transcription in skeletal muscle is regulated by c-Jun terminal kinase/activator protein-1, " Journal of Biological Chemistry, vol. 287, no. 14, pp. 10771-10779, 2012.
82. D. Aronson, M. D. Boppart, S. D. Dufresne, R. A. Fielding, and L. J. Goodyear, "Exercise stimulates c-Jun NH2 kinase activity and c-Jun transcriptional activity in human skeletal muscle, " Biochemical and Biophysical Research Communications, vol. 251, no. 1, pp. 106-110, 1998.
83. M. D. Boppart, S. Asp, J. F. P. Wojtaszewski, R. A. Fielding, T. Mohr, and L. J. Goodyear, "Marathon running transiently increases c-Jun NH2-terminal kinase and p38í activities in human skeletal muscle, " The Journal of Physiology, vol. 526, no. 3, pp. 663-669, 2000.
84. A. J. Galpin, A. C. Fry, L. Z. F. Chiu, D. B. Thomason, and B. K. Schilling, "High-power resistance exercise induces MAPK phosphorylation in weightlifting trained men, " Applied Physiology, Nutrition and Metabolism, vol. 37, no. 1, pp. 80-87, 2012.
85. E. Passos, C. D. Pereira, I. O. Gonçalves et al., "Role of physical exercise on hepatic insulin, glucocorticoid and inflammatory signaling pathways in an animal model of non-alcoholic steatohepatitis, " Life Sciences, vol. 123, pp. 51-60, 2015.
86. J. Jürimäe, P. Hofmann, T. Jürimäe et al., "Plasma adiponectin response to sculling exercise at individual anaerobic threshold in college level male rowers, " International Journal of Sports Medicine, vol. 27, no. 4, pp. 272-277, 2006.
87. C. Punyadeera, A. H. G. Zorenc, R. Koopman et al., "The effects of exercise and adipose tissue lipolysis on plasma adiponectin concentration and adiponectin receptor expression in human skeletalmuscle, "EuropeanJournal of Endocrinology, vol. 152, no. 3, pp. 427-436, 2005.
88. A. D. Kriketos, S. K. Gan, A. M. Poynten, S. M. Furler, D. J. Chisholm, and L. V. Campbell, "Exercise increases adiponectin levels and insulin sensitivity in humans, " Diabetes Care, vol. 27, no. 2, pp. 629-630, 2004.
89. S. Lim, H. C. Sung, I.-K. Jeong et al., "Insulin-sensitizing effects of exercise on adiponectin and retinol-binding protein-4 concentrations in young and middle-aged women, " Journal of Clinical Endocrinology andMetabolism, vol. 93, no. 6, pp. 2263-2268, 2008.
90. V. B. O'Leary, C. M. Marchetti, R. K. Krishnan, B. P. Stetzer, F. Gonzalez, and J. P. Kirwan, "Exercise-induced reversal of insulin resistance in obese elderly is associated with reduced visceral fat, " Journal of Applied Physiology, vol. 100, no. 5, pp. 1584-1589, 2006.
91. K. A. Simpson and M. A. F. Singh, "Effects of exercise on adiponectin: A systematic review, " Obesity, vol. 16, no. 2, pp. 241-256, 2008.
92. T. Kondo, I. Kobayashi, and M. Murakami, "Effect of exercise on circulating adipokine levels in obese young women, " Endocrine Journal, vol. 53, no. 2, pp. 189-195, 2006.
93. I. G. Fatouros, S. Tournis, D. Leontsini et al., "Leptin and adiponectin responses in overweight inactive elderly following resistance training and detraining are intensity related, " Journal of Clinical Endocrinology and Metabolism, vol. 90, no. 11, pp. 5970-5977, 2005.
94. J. K. Cho, S. Kim, H. R. Hong, J. H. Yoon, and H. Kang, "Exercise training improveswhole body insulin resistance via adiponectin receptor 1, " International Journal of Sports Medicine, 2016.
95. C. Frøsig, A. J. Rose, J. T. Treebak, B. Kiens, E. A. Richter, and J. F. P. Wojtaszewski, "Effects of endurance exercise training on insulin signaling in human skeletal muscle: Interactions at the level of phosphatidylinositol 3-kinase, Akt, and AS160, " Diabetes, vol. 56, no. 8, pp. 2093-2102, 2007.
96. M. K. Holten, M. Zacho, M. Gaster, C. Juel, J. F. P. Wojtaszewski, and F. Dela, "Strength training increases insulin-mediated glucose uptake, GLUT4 content, and insulin signaling in skeletal muscle in patients with type 2 diabetes, " Diabetes, vol. 53, no. 2, pp. 294-305, 2004.
97. N. Fujii, M. F. Hirshman, E. M. Kane et al., "AMP-activated protein kinase í2 activity is not essential for contraction-and hyperosmolarity-induced glucose transport in skeletal muscle, " Journal of Biological Chemistry, vol. 280, no. 47, pp. 39033-39041, 2005.
98. J. Jeppesen, S. J. Maarbjerg, A. B. Jordy et al., "LKB1 regulates lipid oxidation during exercise independently of AMPK, " Diabetes, vol. 62, no. 5, pp. 1490-1499, 2013.
99. N. Lefort, E. St-Amand, S. Morasse, C. H. Côté, and A. Marette, "The í-subunit of AMPK is essential for submaximal contraction-mediated glucose transport in skeletal muscle in vitro, " The American Journal of Physiology-Endocrinology and Metabolism, vol. 295, no. 6, pp. E1447-E1454, 2008.
100. K. Sakamoto, A. McCarthy, D. Smith et al., "Deficiency of LKB1 in skeletal muscle prevents AMPK activation and glucose uptake during contraction, " The EMBO Journal, vol. 24, no. 10, pp. 1810-1820, 2005.
101. L. Sylow, T. E. Jensen, M. Kleinert et al., "Rac1 signaling is required for insulin-stimulated glucose uptake and is dysregulated in insulin-resistant murine and human skeletal muscle, " Diabetes, vol. 62, no. 6, pp. 1865-1875, 2013.
102. C. A. Witczak, N. Fujii, M. F. Hirshman, and L. J. Goodyear, "Ca2+/calmodulin-dependent protein kinase kinase-í regulates skeletal muscle glucose uptake independent of AMP-activated protein kinase and Akt activation, " Diabetes, vol. 56, no. 5, pp. 1403-1409, 2007.
103. C. A. Witczak, N. Jessen, D. M. Warro et al., "CaMKII regulates contraction-but not insulin-induced glucose uptake in mouse skeletal muscle, " American Journal of Physiology- Endocrinology andMetabolism, vol. 298, no. 6, pp. E1150-E1160, 2010.
104. C. Keller, A. Steensberg, H. Pilegaard et al., "Transcriptional activation of the IL-6 gene in human contracting skeletal muscle: influence of muscle glycogen content, " The FASEB Journal, vol. 15, no. 14, pp. 2748-2750, 2001.
105. M. A. Febbraio, N. Hiscock, M. Sacchetti, C. P. Fischer, and B. K. Pedersen, "Interleukin-6 is a novel factor mediating glucose homeostasis during skeletal muscle contraction, " Diabetes, vol. 53, no. 7, pp. 1643-1648, 2004.
106. K. Ostrowski, T. Rohde, S. Asp, P. Schjerling, and B. K. Pedersen, "Pro-and anti-inflammatory cytokine balance in strenuous exercise in humans, " The Journal of Physiology, vol. 515, no. 1, pp. 287-291, 1999.
107. R. L. Starkie, J. Rolland, D. J. Angus, M. J. Anderson, and M. A. Febbraio, "Circulating monocytes are not the source of elevations in plasma IL-6 and TNF-í levels after prolonged running, " American Journal of Physiology-Cell Physiology, vol. 280, no. 4, pp. C769-C774, 2001.
108. K. Suzuki, M. Yamada, S. Kurakake et al., "Circulating cytokines and hormones with immunosuppressive but neutrophil-priming potentials rise after endurance exercise in humans, " European Journal of Applied Physiology, vol. 81, no. 4, pp. 281-287, 2000.
109. S. R. Gray, G. Baker, A. Wright, C. F. Fitzsimons, N. Mutrie, and M. A. Nimmo, "The effect of a 12 week walking intervention on markers of insulin resistance and systemic inflammation, " Preventive Medicine, vol. 48, no. 1, pp. 39-44, 2009.
110. M. Roden, "Exercise in type 2 diabetes: To resist or to endure?" Diabetologia, vol. 55, no. 5, pp. 1235-1239, 2012.
111. K. S. C. Röckl, C. A. Witczak, and L. J. Goodyear, "Signaling mechanisms in skeletal muscle: Acute responses and chronic adaptations to exercise, " IUBMB Life, vol. 60, no. 3, pp. 145-153, 2008.
112. J. R. Zierath, A. Krook, and H. Wallberg-Henriksson, "Insulin action and insulin resistance in human skeletal muscle, " Diabetologia, vol. 43, no. 7, pp. 821-835, 2000.
113. M. Björnholm, Y. Kawano, M. Lehtihet, and J. R. Zierath, "Insulin receptor substrate-1 phosphorylation and phosphatidylinositol 3-kinase activity in skeletal muscle from NIDDM subjects after in vivo insulin stimulation, " Diabetes, vol. 46, no. 3, pp. 524-527, 1997.
114. A. Krook, R. A. Roth, X. J. Jiang, J. R. Zierath, and H. Wallberg-Henriksson, "Insulin-stimulated Akt kinase activity is reduced in skeletal muscle from NIDDM subjects, " Diabetes, vol. 47, no. 8, pp. 1281-1286, 1998.
115. J. W. Ryder, J. Yang, D. Galuska et al., "Use of a novel impermeable biotinylated photolabeling reagent to assess insulinand hypoxia-stimulated cell surface GLUT4 content in skeletal muscle from type 2 diabetic patients, " Diabetes, vol. 49, no. 4, pp. 647-654, 2000.
116. J. R. Zierath, L. He, A. Gumà, E. Odegaard Wahlström, A. Klip, and H. Wallberg-Henriksson, "Insulin action on glucose transport and plasma membrane GLUT4 content in skeletal muscle from patients with NIDDM, " Diabetologia, vol. 39, no. 10, pp. 1180-1189, 1996.
117. V. A. Lira, C. R. Benton, Z. Yan, and A. Bonen, "PGC-1í regulation by exercise training and its influences on muscle function and insulin sensitivity, " The American Journal of Physiology-Endocrinology and Metabolism, vol. 299, no. 2, pp. E145-E161, 2010.
118. B. B. Kahn, T. Alquier, D. Carling, and D. G. Hardie, "AMPactivated protein kinase: Ancient energy gauge provides clues to modern understanding of metabolism, " Cell Metabolism, vol. 1, no. 1, pp. 15-25, 2005.
119. D. R. Park, K. H. Park, B. J. Kim, C. S. Yoon, and U. H. Kim, "Exercise ameliorates insulin resistance via Ca2+ signals distinct from those of insulin for GLUT4 translocation in skeletal muscles, " Diabetes, vol. 64, no. 4, pp. 1224-1234, 2015.
120. J. T. Lanner, J. D. Bruton, A. Katz, and H. Westerblad, "Ca2+ and insulin-mediated glucose uptake, " Current Opinion in Pharmacology, vol. 8, no. 3, pp. 339-345, 2008.
121. D. C. Wright, K. A. Hucker, J. O. Holloszy, and D. H. Han, "Ca2+ and AMPK both mediate stimulation of glucose transport by muscle contractions, " Diabetes, vol. 53, no. 2, pp. 330-335, 2004.
122. R. Rashmi, C. DeSelm, C. Helms et al., "AKT inhibitors promote cell death in cervical cancer through disruption of mTOR signaling and glucose uptake, " PLoS ONE, vol. 9, no. 4, Article ID e92948, 2014.
123. C. L. Buller, R. D. Loberg, M.-H. Fan et al., "A GSK-3/TSC2/mTOR pathway regulates glucose uptake and GLUT1 glucose transporter expression, " The American Journal of Physiology-Cell Physiology, vol. 295, no. 3, pp. C836-C843, 2008.
124. M. J. Pereira, J. Palming, M. Rizell et al., "mTOR inhibition with rapamycin causes impaired insulin signalling and glucose uptake in human subcutaneous and omental adipocytes, " Molecular and Cellular Endocrinology, vol. 355, no. 1, pp. 96-105, 2012.
125. M. Kleinert, L. Sylow, D. J. Fazakerley et al., "Acute mTOR inhibition induces insulin resistance and alters substrate utilization in vivo, " Molecular Metabolism, vol. 3, no. 6, pp. 630-641, 2014.
126. M. Fraenkel, M. Ketzinel-Gilad, Y. Ariav et al., "mTOR inhibition by rapamycin prevents í-cell adaptation to hyperglycemia and exacerbates the metabolic state in type 2 diabetes, " Diabetes, vol. 57, no. 4, pp. 945-957, 2008.
127. S. C. Bodine, T. N. Stitt, M. Gonzalez et al., "Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo, " Nature Cell Biology, vol. 3, no. 11, pp. 1014-1019, 2001.
128. M. Sandri, "Signaling in muscle atrophy and hypertrophy, " Physiology, vol. 23, no. 3, pp. 160-170, 2008.
129. S. Klossner, A.-C. Durieux, D. Freyssenet, and M. Flueck, "Mechano-transduction to muscle protein synthesis is modulated by FAK, " European Journal of Applied Physiology, vol. 106, no. 3, pp. 389-398, 2009.
130. K. Huang and D. C. Fingar, "Growing knowledge of the mTOR signaling network, " Seminars in Cell andDevelopmental Biology, vol. 36, pp. 79-90, 2014.
131. H. F. Kramer, C. A. Witczak, E. B. Taylor, N. Fujii, M. F. Hirshman, and L. J. Goodyear, "AS160 regulates insulinand contraction-stimulated glucose uptake in mouse skeletal muscle, "The Journal of Biological Chemistry, vol. 281, no. 42, pp. 31478-31485, 2006.
132. K. Vichaiwong, S. Purohit, D. An et al., "Contraction regulates site-specific phosphorylation of TBC1D1 in skeletal muscle, " Biochemical Journal, vol. 431, no. 2, pp. 311-320, 2010.
133. C. Y. Christ-Roberts, T. Pratipanawatr, W. Pratipanawatr, R. Berria, R. Belfort, and L. J. Mandarino, "Increased insulin receptor signaling and glycogen synthase activity contribute to the synergistic effect of exercise on insulin action, " Journal of Applied Physiology, vol. 95, no. 6, pp. 2519-2529, 2003.
134. L. JeBailey, O. Wanono, W. Niu, J. Roessler, A. Rudich, and A. Klip, "Ceramide-and oxidant-induced insulin resistance involve loss of insulin-dependent Rac-activation and actin remodeling in muscle cells, " Diabetes, vol. 56, no. 2, pp. 394-403, 2007.
135. H. Cho, J. Mu, J. K. Kim et al., "Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKBí), " Science, vol. 292, no. 5522, pp. 1728-1731, 2001.
136. P. H. Albers, A. J. T. Pedersen, J. B. Birk et al., "Humanmuscle fiber type-specific insulin signaling: impact of obesity and type 2 diabetes, " Diabetes, vol. 64, no. 2, pp. 485-497, 2015.
137. O. S. Kwon, R. E. Tanner, K. M. Barrows et al., "MyD88 regulates physical inactivity-induced skeletal muscle inflammation, ceramide biosynthesis signaling, and glucose intolerance, " The American Journal of Physiology-Endocrinology and Metabolism, vol. 309, no. 1, pp. E11-E21, 2015.
138. S. Akira and S. Sato, "Toll-like receptors and their signaling mechanisms, " Scandinavian Journal of Infectious Diseases, vol. 35, no. 9, pp. 555-562, 2003.
139. L. Chen, R. Chen, H. Wang, and F. Liang, "Mechanisms linking inflammation to insulin resistance, " International Journal of Endocrinology, vol. 2015, Article ID 508409, 9 pages, 2015.
140. A. Steensberg, C. P. Fischer, C. Keller, K. Møller, and B. K. Pedersen, "IL-6 enhances plasma IL-1ra, IL-10, and cortisol in humans, " The American Journal of Physiology-Endocrinology and Metabolism, vol. 285, no. 2, pp. E433-E437, 2003.
141. H. Wen, E. A. Miao, and J. P.-Y. Ting, "Mechanisms of NODlike receptor-associated inflammasome activation, " Immunity, vol. 39, no. 3, pp. 432-441, 2013.
142. J. Jager, T. Grémeaux, M. Cormont, Y. Le Marchand-Brustel, and J.-F. Tanti, "Interleukin-1í-induced insulin resistance in adipocytes through down-regulation of insulin receptor substrate-1 expression, " Endocrinology, vol. 148, no. 1, pp. 241-251, 2007.
143. C. Herder, E. Dalmas, M. Böni-Schnetzler, and M. Y. Donath, "The IL-1 pathway in type 2 diabetes and cardiovascular complications, " Trends in Endocrinology & Metabolism, vol. 26, no. 10, pp. 551-563, 2015.
144. H. F. Kramer and L. J. Goodyear, "Exercise, MAPK, and NF-íB signaling in skeletal muscle, " Journal of Applied Physiology, vol. 103, no. 1, pp. 388-395, 2007.
145. Z. Gao, D. Hwang, F. Bataille et al., "Serine phosphorylation of insulin receptor substrate 1 by inhibitor íBkinase complex, "The Journal of Biological Chemistry, vol. 277, no. 50, pp. 48115-48121, 2002.
146. K. Müssig, H. Staiger, H. Fiedler et al., "Shp2 is required for protein kinase C-dependent phosphorylation of serine 307 in insulin receptor substrate-1, " Journal of Biological Chemistry, vol. 280, no. 38, pp. 32693-32699, 2005.
147. K. Müssig, H. Fiedler, H. Staiger et al., "Insulin-induced stimulation of JNK and the PI 3-kinase/mTOR pathway leads to phosphorylation of serine 318 of IRS-1 in C2C12 myotubes, " Biochemical and Biophysical Research Communications, vol. 335, no. 3, pp. 819-825, 2005.
148. E. Kefaloyianni, C. Gaitanaki, and I. Beis, "ERK1/2 and p38-MAPK signalling pathways, through MSK1, are involved in NF-íB transactivation during oxidative stress in skeletalmyoblasts, " Cellular Signalling, vol. 18, no. 12, pp. 2238-2251, 2006.
149. M. Karin and E. Gallagher, "From JNK to pay dirt: jun kinases, their biochemistry, physiology and clinical importance, " IUBMB Life, vol. 57, no. 4-5, pp. 283-295, 2005.
150. T. Kadowaki, K. Hara, T. Yamauchi, Y. Terauchi, K. Tobe, and R. Nagai, "Molecularmechanismof insulin resistance and obesity, " Experimental Biology andMedicine, vol. 228, no. 10, pp. 1111-1117, 2003.
151. M. J. Yoon, G. Y. Lee, J. J. Chung, Y. H. Ahn, S. H. Hong, and J. B. Kim, "Adiponectin increases fatty acid oxidation in skeletal muscle cells by sequential activation of AMP-activated protein kinase, p38 mitogen-activated protein kinase, and peroxisome proliferator-activated receptor alpha, " Diabetes, vol. 55, no. 9, pp. 2562-2570, 2006.
152. X. Mao, C. K. Kikani, R. A. Riojas et al., "APPL1 binds to adiponectin receptors and mediates adiponectin signalling and function, " Nature Cell Biology, vol. 8, no. 5, pp. 516-523, 2006.
153. C. Herder, M. Carstensen, and D. M. Ouwens, "Antiinflammatory cytokines and risk of type 2 diabetes, " Diabetes, Obesity and Metabolism, vol. 15, no. 3, pp. 39-50, 2013.
154. K. Ohashi, R. Shibata, T. Murohara, and N. Ouchi, "Role of antiinflammatory adipokines in obesity-related diseases, " Trends in Endocrinology andMetabolism, vol. 25, no. 7, pp. 348-355, 2014.
155. M. Okada-Iwabu, T. Yamauchi, M. Iwabu et al., "A smallmolecule AdipoR agonist for type 2 diabetes and short life in obesity, " Nature, vol. 503, no. 7477, pp. 493-499, 2013.
156. L. M. Belalcazar, W. Lang, S. M. Haffner et al., "Improving adiponectin levels in individuals with diabetes and obesity: insights from Look AHEAD, " Diabetes Care, vol. 38, no. 8, pp. 1544-1550, 2015.
157. L. M. Belalcazar, W. Lang, S. M. Haffner et al., "Adiponectin and the mediation of HDL-cholesterol change with improved lifestyle: The look AHEAD study, " Journal of Lipid Research, vol. 53, no. 12, pp. 2726-2733, 2012.
158. Y. Deng and P. E. Scherer, "Adipokines as novel biomarkers and regulators of the metabolic syndrome, " Annals of the New York Academy of Sciences, vol. 1212, pp. E1-E19, 2010.
159. C. Herder, M. Peltonen, P.-A. Svensson et al., "Adiponectin and bariatric surgery: Associations with diabetes and cardiovascular disease in the SwedishObese Subjects Study, " Diabetes Care, vol. 37, no. 5, pp. 1401-1409, 2014.
160. B. K. Pedersen and H. Bruunsgaard, "Possible beneficial role of exercise in modulating low-grade inflammation in the elderly, " Scandinavian Journal of Medicine and Science in Sports, vol. 13, no. 1, pp. 56-62, 2003.
161. C. Herder, J. Baumert, A. Zierer et al., "Immunological and cardiometabolic risk factors in the prediction of type 2 diabetes and coronary events: MONICA/KORA Augsburg case-cohort study, " PLoS ONE, vol. 6, no. 6, Article ID e19852, 2011.
162. C. Herder, J. Baumert, B. Thorand et al., "Chemokines as risk factors for type 2 diabetes: results from the MONICA/KORA Augsburg study, 1984-2002, " Diabetologia, vol. 49, no. 5, pp. 921-929, 2006.
163. C. Herder, M. Peltonen, W. Koenig et al., "Anti-inflammatory effect of lifestyle changes in the Finnish Diabetes Prevention Study, " Diabetologia, vol. 52, no. 3, pp. 433-442, 2009.
164. F. Ribeiro, A. J. Alves, J. A. Duarte, and J. Oliveira, "Is exercise training an effective therapy targeting endothelial dysfunction and vascular wall inflammation?" International Journal of Cardiology, vol. 141, no. 3, pp. 214-221, 2010.
165. P. L. Gordon, E. Vannier, K. Hamada et al., "Resistance training alters cytokine gene expression in skeletalmuscle of adults with type 2 diabetes, " International Journal of Immunopathology and Pharmacology, vol. 19, no. 4, pp. 739-749, 2006.
166. G. S. Hotamisligil, "The role of TNFí and TNF receptors in obesity and insulin resistance, " Journal of InternalMedicine, vol. 245, no. 6, pp. 621-625, 1999.
167. R. Halse, S. L. Pearson, J. G. McCormack, S. J. Yeaman, and R. Taylor, "Effects of tumor necrosis factor-í on insulin action in cultured human muscle cells, " Diabetes, vol. 50, no. 5, pp. 1102-1109, 2001.
168. J. M. Youd, S. Rattigan, and M. G. Clark, "Acute impairment of insulin-mediated capillary recruitment and glucose uptake rat skeletal muscle vivo by TNF-í, " Diabetes, vol. 49, no. 11, pp. 1904-1909, 2000.
169. M. A. Nimmo, M. Leggate, J. L. Viana, and J. A. King, "The effect of physical activity on mediators of inflammation, " Diabetes, Obesity and Metabolism, vol. 15, no. 3, pp. 51-60, 2013.
170. B. K. Pedersen and M. A. Febbraio, "Point: interleukin-6 does have a beneficial role in insulin sensitivity and glucose homeostasis, " Journal of Applied Physiology, vol. 102, no. 2, pp. 814-816, 1985.
171. F.-C. Hsu, S. B. Kritchevsky, Y. Liu et al., "Association between inflammatory components and physical function in the health, aging, and body composition study: A principal component analysis approach, " Journals of Gerontology-Series A: Biological Sciences and Medical Sciences, vol. 64, no. 5, pp. 581-589, 2009.
172. M. Hawkins, L. M. Belalcazar, K. B. Schelbert, C. Richardson, C. M. Ballantyne, and A. Kriska, "Theeffect of various intensities of physical activity and chronic inflammation in men and women by diabetes status in a national sample, " Diabetes Research and Clinical Practice, vol. 97, no. 1, pp. e6-e8, 2012.
173. K. D. Flack, K. P. Davy, M. W. Hulver, R. A. Winett, M. I. Frisard, and B. M. Davy, "Aging, resistance training, and diabetes prevention, " Journal of AgingResearch, vol. 2011, Article ID 127315, 12 pages, 2011.
174. J. Yin, Z. Hao, Y. Ma et al., "Concomitant activation of the PI3K/Akt and ERK1/2 signalling is involved in cyclic compressive force-induced IL-6 secretion in MLO-Y4 cells, " Cell Biology International, vol. 38, no. 5, pp. 591-598, 2014.
175. T. H. Kim, S. E. Choi, E. S. Ha et al., "IL-6 induction of TLR-4 gene expression via STAT3 has an effect on insulin resistance in human skeletal muscle, " Acta Diabetologica, vol. 50, no. 2, pp. 189-200, 2013.
176. M. A. Febbraio, "Role of interleukins in obesity: implications formetabolic disease, " Trends in Endocrinology andMetabolism, vol. 25, no. 6, pp. 312-319, 2014.